Thermo Fisher Scientific Inc. TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other…
| Quarter | Revenue | Net Income | EPS (dil.) | Gross Margin |
|---|---|---|---|---|
| 2026 Q1 | — | $1.65B | 4.43 | 40.3% |
| 2025 Q4 | — | $1.96B | 5.21 | 41.0% |
| 2025 Q3 | — | $1.62B | 4.27 | 41.2% |
| 2025 Q2 | — | $1.62B | 4.28 | 40.6% |
